Glycosylation promotes the cancer regulator EGFR-ErbB2 heterodimer formation — molecular dynamics study

• Published in: Journal of molecular modeling Vol. 27; no. 12; p. 361
• Main Authors: Motamedi, Zahra, Rajabi-Maham, Hassan, Azimzadeh Irani, Maryam
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.12.2021; Springer Nature B.V
• Subjects: Binding Sites; Cancer; Characterization and Evaluation of Materials; Chemistry; Chemistry and Materials Science; Computer Appl. in Life Sciences; Computer Applications in Chemistry; Differentiation (biology); Dimerization; Domains; Dynamic stability; ErbB Receptors - chemistry; ErbB Receptors - metabolism; Glycosylation; Growth factors; Homology; Humans; Hydrophobic and Hydrophilic Interactions; Interface stability; Kinases; Ligands; Models, Molecular; Molecular dynamics; Molecular Dynamics Simulation; Molecular Medicine; Mutation; Neoplasms - metabolism; Occlusion; Original Paper; Protein Interaction Domains and Motifs; Protein Multimerization; Receptor, ErbB-2 - chemistry; Receptor, ErbB-2 - metabolism; Receptors; Theoretical and Computational Chemistry; Tyrosine; Glycosylation; Molecular dynamics simulations; ErbB2; Heterodimer; EGFR
• ISSN: 1610-2940; 0948-5023
• DOI: 10.1007/s00894-021-04986-9

ErbB family of receptor tyrosine kinases play significant roles in cellular differentiation and proliferation. Mutation or overexpression of these receptors leads to several cancers in humans. The family has four homologous members including EGFR, ErbB2, ErbB3, and ErbB4. From which all except the ErbB2 bind to growth factors via the extracellular domain to send signals to the cell. However, dimerization of the ErbB receptor occurs in extracellular, transmembrane, and intracellular domains. The ErbB receptors are known to form homodimers and heterodimers in the active form. Heterodimerization increases the variety of identified ligands and signaling pathways that can be activated by these receptors. Furthermore, glycosylation of the ErbB receptors has shown to be critical for their stability, ligand binding, and dimerization. Here, atomistic molecular dynamics simulations on the glycosylated and unglycosylated heterodimer showed that the EGFR-ErbB2 heterodimer is more stable in its dynamical pattern compared to the EGFR-EGFR homodimer. This increased stability is regulated by maintaining the dimeric interface by the attached glycans. It was also shown that the presence of various glycosylation sites within the ErbB2 growth factor binding site leads to occlusion of this site by the glycans that inhibit ligand binding to ErbB2 and participate in further stabilization of the heterodimer construct. Putting together, glycosylation seems to promote the heterodimer formation within the ErbB family members as the dominant molecular mechanism of activation for these receptors.